TLGT News and Press, Teligent Inc.

Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process Company is arranging $12 million debtor-in-possession financing from its senior secured lenders and access to its cash collateral on a consensual basis Canadian entities to pursue sale process outside of Chap...

3 Penny Stocks to Watch With September Halfway Done With September already at the halfway point, there are plenty of penny stocks that investors are watching. And while it may seem easy at first to find valuable penny stocks to buy, it does take some time and a dedication to researc...

Teligent, Inc. (TLGT) Q2 2021 Results Conference Call August 16, 2021 08:30 AM ET Company Participants Philip Yachmetz - Chief Legal Officer and Corporate Secretary Tim Sawyer - President and Chief Executive Officer Ernie De Paolantonio - Chief Financial Officer Conference Call Participants M...

BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a business update. “Product demand in our core busin...

BUENA, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conference call at 8:30AM ET on Monday, August 16th, 2021 to discuss the...

Scheduled to Reconvene on June 30, 2021 Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 18, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the “Company”), announced today tha...

3 Biotech Penny Stocks to Watch in June 2021 Biotech penny stocks have remained in focus throughout the pandemic. This makes sense given the major emphasis on pandemic-related companies. However, a year and a half later, that emphasis now is on biotech penny stocks that have little ...

Teligent, Inc. (TLGT) Q1 2021 Earnings Conference Call May 25, 2021 8:30 AM ET Company Participants Philip Yachmetz – Chief Legal Officer and Corporate Secretary Tim Sawyer – President and Chief Executive Officer Ernie De Paolantonio – Chief Financial Officer Conference C...

Teligent (TLGT): Q1 GAAP EPS of $0.03 beats by $2.04.Revenue of $11.6M (+55.7% Y/Y) beats by $0.6M.As previously noted in 2020 year-end earnings release, the Company will not be providing financial guidance for the year ending December 31, 2021 at this time or in the immediate term....

BUENA, N.J., May 25, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the first quarter of 2021 and provided a business update. “As we prepare for the second half of 202...